Symbol:
Cyp4b1
Name:
cytochrome P450, family 4, subfamily b, polypeptide 1
RGD ID:
10457
MGI Page
MGI
Description:
Predicted to enable heterocyclic compound binding activity. Predicted to be involved in biphenyl metabolic process. Predicted to be located in endoplasmic reticulum membrane. Is expressed in several structures, including liver; lung; male reproductive gland or organ; metanephros; and spleen. Orthologous to human CYP4B1 (cytochrome P450 family 4 subfamily B member 1).
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
CYPIVB1; cytochrome P450 4B1; cytochrome P450, subfamily IV B, polypeptide 1
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
CYP4B1 (cytochrome P450 family 4 subfamily B member 1) HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Cyp4b1 (cytochrome P450, family 4, subfamily b, polypeptide 1) RGD
RGD
Chinchilla lanigera (long-tailed chinchilla):
LOC102012414 (cytochrome P450 4B1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
CYP4B1 (cytochrome P450 family 4 subfamily B member 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
CYP4B1 (cytochrome P450 family 4 subfamily B member 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
LOC101955242 (cytochrome P450 4B1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
CYP4B1 (cytochrome P450 family 4 subfamily B member 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
CYP4B1 (cytochrome P450 family 4 subfamily B member 1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
LOC101725929 (cytochrome P450 4B1) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Cyp4b1 (cytochrome P450, family 4, subfamily b, polypeptide 1)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
CYP4B1 (cytochrome P450 family 4 subfamily B member 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp4t8 (cytochrome P450, family 4, subfamily T, polypeptide 8)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Cyp4p3
Alliance
DIOPT (Ensembl Compara|OMA|PhylomeDB)
Drosophila melanogaster (fruit fly):
Cyp4d14
Alliance
DIOPT (Ensembl Compara|OMA|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
cyp4b1.5
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Related Pseudogenes:
Cyp4b1-ps1
Cyp4b1-ps2
Latest Assembly:
GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 115,481,895 - 115,504,918 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 115,481,922 - 115,504,920 (-) Ensembl GRCm39 Ensembl GRCm38 4 115,624,698 - 115,647,721 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 115,624,725 - 115,647,723 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 115,297,333 - 115,320,310 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 115,122,660 - 115,145,637 (-) NCBI MGSCv36 mm8 Celera 4 114,360,727 - 114,383,719 (-) NCBI Celera Cytogenetic Map 4 D1 NCBI cM Map 4 53.06 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Cyp4b1 Mouse 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CYP4B1 mRNA CTD PMID:22206623 Cyp4b1 Mouse 1-naphthyl isothiocyanate decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP4B1 mRNA CTD PMID:30723492 Cyp4b1 Mouse 17alpha-ethynylestradiol decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of CYP4B1 mRNA CTD PMID:16174780 and PMID:17351261 Cyp4b1 Mouse 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CYP4B1 mRNA CTD PMID:16174780 and PMID:17942748 Cyp4b1 Mouse 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CYP4B1 mRNA CTD PMID:17942748 Cyp4b1 Mouse 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of CYP4B1 mRNA CTD PMID:17555576 Cyp4b1 Mouse 17beta-estradiol multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CYP4B1 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of CYP4B1 mRNA CTD PMID:17404688 and PMID:30165855 Cyp4b1 Mouse 17beta-estradiol decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Estradiol results in decreased expression of CYP4B1 mRNA CTD PMID:31614463 Cyp4b1 Mouse 17beta-estradiol decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of CYP4B1 mRNA CTD PMID:26945725 Cyp4b1 Mouse 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP4B1 mRNA CTD PMID:14664709 and PMID:39298647 Cyp4b1 Mouse 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 2 more ... CTD PMID:20566336 Cyp4b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP4B1 mRNA CTD PMID:21215274 Cyp4b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP4B1 mRNA CTD PMID:32109520 Cyp4b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP4B1 mRNA CTD PMID:28213091 Cyp4b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP4B1 mRNA CTD PMID:16985168 more ... Cyp4b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CYP4B1 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP4B1 gene] CTD PMID:17942748 and PMID:28213091 Cyp4b1 Mouse 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 Cyp4b1 Mouse 2-naphthylamine increases metabolic processing ISO Cyp4b1 (Rattus norvegicus) 6480464 CYP4B1 protein results in increased metabolism of 2-Naphthylamine CTD PMID:9310344 Cyp4b1 Mouse 2-naphthylamine increases metabolic processing EXP 6480464 CYP4B1 protein results in increased metabolism of 2-Naphthylamine CTD PMID:9310344 Cyp4b1 Mouse 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 Cyp4b1 Mouse 3,3'-Dichlorobenzidine increases metabolic processing ISO Cyp4b1 (Rattus norvegicus) 6480464 CYP4B1 protein results in increased metabolism of 3 and 3'-Dichlorobenzidine CTD PMID:9310344 Cyp4b1 Mouse 3,3'-Dichlorobenzidine increases metabolic processing EXP 6480464 CYP4B1 protein results in increased metabolism of 3 and 3'-Dichlorobenzidine CTD PMID:9310344 Cyp4b1 Mouse 3,3'-Dichlorobenzidine multiple interactions EXP 6480464 lauric acid inhibits the reaction [CYP4B1 protein results in increased metabolism of 3 and 3'-Dichlorobenzidine] CTD PMID:9310344 Cyp4b1 Mouse 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of CYP4B1 mRNA CTD PMID:26251327 Cyp4b1 Mouse 3,4-methylenedioxymethamphetamine increases methylation EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of CYP4B1 promoter CTD PMID:26251327 Cyp4b1 Mouse 3-chloropropane-1,2-diol multiple interactions EXP 6480464 [alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of CYP4B1 mRNA CTD PMID:33187795 Cyp4b1 Mouse 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP4B1 mRNA CTD PMID:28628672 Cyp4b1 Mouse 3-methylbenzyl alcohol decreases activity ISO Cyp4b1 (Rattus norvegicus) 6480464 3-methylbenzyl alcohol results in decreased activity of CYP4B1 protein CTD PMID:12791539 Cyp4b1 Mouse 3-methylcholanthrene increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Methylcholanthrene results in increased expression of CYP4B1 mRNA CTD PMID:23273579 Cyp4b1 Mouse 3-methyleneindolenine multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [CYP4B1 protein results in increased metabolism of Skatole] which results in increased chemical synthesis of 3-methyleneindolenine CTD PMID:20187624 Cyp4b1 Mouse 3H-1,2-dithiole-3-thione decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in decreased expression of CYP4B1 mRNA CTD PMID:19162173 Cyp4b1 Mouse 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bisphenol S affects the methylation of CYP4B1 gene CTD PMID:31683443 Cyp4b1 Mouse 4-Ipomeanol affects metabolic processing ISO Cyp4b1 (Rattus norvegicus) 6480464 CYP4B1 protein affects the metabolism of 4-ipomeanol CTD PMID:8248926 Cyp4b1 Mouse 4-Ipomeanol affects binding ISO Cyp4b1 (Rattus norvegicus) 1626415 4-Ipomeanol binds to Cyp4b1 protein RGD Cyp4b1 Mouse 4-Ipomeanol multiple interactions EXP 6480464 CYP4B1 protein results in increased susceptibility to and results in increased metabolism of and results in increased activity of 4-ipomeanol CTD PMID:23748241 Cyp4b1 Mouse 4-Ipomeanol increases response to substance ISO Cyp4b1 (Rattus norvegicus) 6480464 CYP4B1 protein results in increased susceptibility to 4-ipomeanol CTD PMID:8248926 Cyp4b1 Mouse 4-Ipomeanol decreases response to substance EXP 6480464 CYP4B1 gene mutant form results in decreased susceptibility to 4-ipomeanol CTD PMID:23748241 Cyp4b1 Mouse 6-propyl-2-thiouracil decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of CYP4B1 mRNA CTD PMID:30047161 Cyp4b1 Mouse acrolein multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CYP4B1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CYP4B1 mRNA CTD PMID:32699268 Cyp4b1 Mouse aflatoxin B1 decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of CYP4B1 mRNA CTD PMID:32234424 Cyp4b1 Mouse all-trans-retinoic acid increases expression ISO CYP4B1 (Homo sapiens) 6480464 Tretinoin results in increased expression of CYP4B1 mRNA CTD PMID:16249480 Cyp4b1 Mouse all-trans-retinoic acid decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of CYP4B1 mRNA CTD PMID:16985168 Cyp4b1 Mouse alpha-pinene multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CYP4B1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CYP4B1 mRNA CTD PMID:32699268 Cyp4b1 Mouse alpha-Zearalanol multiple interactions ISO Cyp4b1 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CYP4B1 mRNA CTD PMID:35163327 Cyp4b1 Mouse amitrole decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Amitrole results in decreased expression of CYP4B1 mRNA CTD PMID:30047161 Cyp4b1 Mouse ammonium chloride affects expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CYP4B1 mRNA CTD PMID:16483693 Cyp4b1 Mouse amphotericin B decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Amphotericin B analog results in decreased expression of CYP4B1 mRNA CTD PMID:28534445 Cyp4b1 Mouse aristolochic acid A multiple interactions ISO Cyp4b1 (Rattus norvegicus) 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CYP4B1 mRNA CTD PMID:23912714 Cyp4b1 Mouse Azoxymethane multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4B1 mRNA CTD PMID:29950665 Cyp4b1 Mouse benzo[a]pyrene decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CYP4B1 mRNA CTD PMID:20106945 Cyp4b1 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CYP4B1 protein CTD PMID:34472326 Cyp4b1 Mouse benzo[a]pyrene affects methylation ISO CYP4B1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CYP4B1 3' UTR and Benzo(a)pyrene affects the methylation of CYP4B1 promoter CTD PMID:27901495 Cyp4b1 Mouse benzo[a]pyrene increases methylation ISO CYP4B1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CYP4B1 exon CTD PMID:27901495 Cyp4b1 Mouse benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CYP4B1 mRNA CTD PMID:22228805 and PMID:23735875 Cyp4b1 Mouse benzo[b]fluoranthene decreases expression EXP 6480464 benzo(b)fluoranthene results in decreased expression of CYP4B1 mRNA CTD PMID:26377693 Cyp4b1 Mouse Benzo[ghi]perylene increases expression ISO CYP4B1 (Homo sapiens) 6480464 1 and 12-benzoperylene results in increased expression of CYP4B1 CTD PMID:27234499 Cyp4b1 Mouse Benzo[ghi]perylene multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [1 and 12-benzoperylene results in increased expression of CYP4B1] CTD PMID:27234499 Cyp4b1 Mouse beta-naphthoflavone decreases expression ISO CYP4B1 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of CYP4B1 mRNA CTD PMID:16985168 and PMID:22258563 Cyp4b1 Mouse bezafibrate affects expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Bezafibrate affects the expression of CYP4B1 mRNA CTD PMID:17719200 Cyp4b1 Mouse bifenthrin decreases expression EXP 6480464 bifenthrin results in decreased expression of CYP4B1 mRNA CTD PMID:26071804 Cyp4b1 Mouse bisphenol A multiple interactions ISO Cyp4b1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of CYP4B1 mRNA CTD PMID:26496021 Cyp4b1 Mouse bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP4B1 mRNA CTD PMID:33221593 Cyp4b1 Mouse bisphenol A multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP4B1 mRNA CTD PMID:28628672 Cyp4b1 Mouse buspirone increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Buspirone results in increased expression of CYP4B1 mRNA CTD PMID:24136188 Cyp4b1 Mouse cadmium dichloride affects expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Cadmium Chloride affects the expression of CYP4B1 mRNA CTD PMID:22110744 Cyp4b1 Mouse cadmium dichloride decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of CYP4B1 mRNA CTD PMID:38568856 Cyp4b1 Mouse cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CYP4B1 mRNA CTD PMID:11958953 Cyp4b1 Mouse cadmium dichloride increases expression ISO CYP4B1 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of CYP4B1 mRNA CTD PMID:12160620 Cyp4b1 Mouse caffeine increases expression ISO CYP4B1 (Homo sapiens) 6480464 Caffeine results in increased expression of CYP4B1 mRNA CTD PMID:18444173 Cyp4b1 Mouse calcidiol decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Calcifediol deficiency results in decreased expression of CYP4B1 mRNA CTD PMID:17293106 Cyp4b1 Mouse calcitriol decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Calcitriol results in decreased expression of CYP4B1 mRNA CTD PMID:27107558 Cyp4b1 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Cyp4b1 Mouse chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CYP4B1 mRNA CTD PMID:37019170 Cyp4b1 Mouse ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of CYP4B1 mRNA CTD PMID:18353800 Cyp4b1 Mouse cobalt atom decreases expression EXP 6480464 Cobalt results in decreased expression of CYP4B1 mRNA CTD PMID:34468815 Cyp4b1 Mouse cobalt dichloride increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of CYP4B1 mRNA CTD PMID:24386269 Cyp4b1 Mouse copper atom increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Copper results in increased expression of CYP4B1 mRNA CTD PMID:22465980 Cyp4b1 Mouse copper(0) increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Copper results in increased expression of CYP4B1 mRNA CTD PMID:22465980 Cyp4b1 Mouse copper(II) chloride decreases expression ISO CYP4B1 (Homo sapiens) 6480464 cupric chloride results in decreased expression of CYP4B1 mRNA CTD PMID:38568856 Cyp4b1 Mouse Cuprizon decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of CYP4B1 mRNA CTD PMID:27523638 Cyp4b1 Mouse cyclosporin A decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CYP4B1 mRNA CTD PMID:20106945 Cyp4b1 Mouse dexamethasone multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP4B1 mRNA CTD PMID:28628672 Cyp4b1 Mouse dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4B1 mRNA CTD PMID:29950665 Cyp4b1 Mouse dodecanoic acid multiple interactions EXP 6480464 lauric acid inhibits the reaction [CYP4B1 protein results in increased metabolism of 3 and 3'-Dichlorobenzidine] CTD PMID:9310344 Cyp4b1 Mouse elemental selenium increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Selenium deficiency results in increased expression of CYP4B1 mRNA CTD PMID:11444866 Cyp4b1 Mouse epoxiconazole increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 epoxiconazole results in increased expression of CYP4B1 mRNA CTD PMID:25182419 Cyp4b1 Mouse ethanol decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Ethanol results in decreased expression of CYP4B1 mRNA CTD PMID:15353170 Cyp4b1 Mouse ethanol increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Ethanol results in increased expression of CYP4B1 mRNA CTD PMID:23273579 Cyp4b1 Mouse ethyl methanesulfonate increases expression ISO CYP4B1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of CYP4B1 mRNA CTD PMID:23649840 Cyp4b1 Mouse fenofibrate multiple interactions ISO Cyp4b1 (Rattus norvegicus) 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA CTD PMID:18253720 Cyp4b1 Mouse fenthion increases expression EXP 6480464 Fenthion results in increased expression of CYP4B1 mRNA CTD PMID:34813904 Cyp4b1 Mouse flavonoids decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Flavonoids results in decreased expression of CYP4B1 mRNA CTD PMID:18035473 Cyp4b1 Mouse flutamide decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of CYP4B1 mRNA CTD PMID:24136188 Cyp4b1 Mouse folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of CYP4B1 mRNA CTD PMID:25629700 Cyp4b1 Mouse genistein decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Genistein results in decreased expression of CYP4B1 mRNA CTD PMID:18444173 Cyp4b1 Mouse genistein increases expression EXP 6480464 Genistein results in increased expression of CYP4B1 mRNA CTD PMID:32186404 Cyp4b1 Mouse glycidol multiple interactions EXP 6480464 [alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of CYP4B1 mRNA CTD PMID:33187795 Cyp4b1 Mouse indometacin multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYP4B1 mRNA CTD PMID:28628672 Cyp4b1 Mouse irinotecan affects expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Irinotecan affects the expression of CYP4B1 mRNA CTD PMID:20097248 Cyp4b1 Mouse ketoconazole increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Ketoconazole results in increased expression of CYP4B1 mRNA CTD PMID:37077353 Cyp4b1 Mouse kojic acid multiple interactions ISO Cyp4b1 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA CTD PMID:18544905 Cyp4b1 Mouse kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CYP4B1 mRNA CTD PMID:17917374 Cyp4b1 Mouse lead diacetate decreases expression ISO CYP4B1 (Homo sapiens) 6480464 lead acetate results in decreased expression of CYP4B1 mRNA CTD PMID:38568856 Cyp4b1 Mouse levofloxacin increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Levofloxacin results in increased expression of CYP4B1 mRNA CTD PMID:24136188 Cyp4b1 Mouse m-tolualdehyde affects activity ISO Cyp4b1 (Rattus norvegicus) 6480464 3-methylbenzaldehyde affects the activity of CYP4B1 protein CTD PMID:12791539 Cyp4b1 Mouse m-xylene affects activity ISO Cyp4b1 (Rattus norvegicus) 6480464 3-xylene affects the activity of CYP4B1 protein CTD PMID:15204773 Cyp4b1 Mouse m-xylene decreases activity ISO Cyp4b1 (Rattus norvegicus) 6480464 3-xylene results in decreased activity of CYP4B1 protein CTD PMID:12791539 and PMID:8598570 Cyp4b1 Mouse methimazole decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Methimazole results in decreased expression of CYP4B1 mRNA CTD PMID:30047161 Cyp4b1 Mouse methylparaben decreases expression ISO CYP4B1 (Homo sapiens) 6480464 methylparaben results in decreased expression of CYP4B1 mRNA CTD PMID:38568856 Cyp4b1 Mouse mifepristone decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Mifepristone results in decreased expression of CYP4B1 mRNA CTD PMID:17584828 Cyp4b1 Mouse Muraglitazar increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 muraglitazar results in increased expression of CYP4B1 mRNA CTD PMID:21515302 Cyp4b1 Mouse N-nitrosodiethylamine multiple interactions ISO Cyp4b1 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA more ... CTD PMID:18253720 more ... Cyp4b1 Mouse N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CYP4B1 mRNA CTD PMID:17917374 Cyp4b1 Mouse nevirapine increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Nevirapine metabolite results in increased expression of CYP4B1 mRNA CTD PMID:23947594 Cyp4b1 Mouse O-methyleugenol decreases expression ISO CYP4B1 (Homo sapiens) 6480464 methyleugenol results in decreased expression of CYP4B1 mRNA CTD PMID:32234424 Cyp4b1 Mouse okadaic acid decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of CYP4B1 mRNA CTD PMID:38832940 Cyp4b1 Mouse orphenadrine affects expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Orphenadrine affects the expression of CYP4B1 mRNA CTD PMID:23665939 Cyp4b1 Mouse oxycodone increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Oxycodone results in increased expression of CYP4B1 mRNA CTD PMID:23439660 Cyp4b1 Mouse ozone decreases expression EXP 6480464 Ozone results in decreased expression of CYP4B1 mRNA CTD PMID:16183385 Cyp4b1 Mouse ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CYP4B1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CYP4B1 mRNA CTD PMID:34911549 Cyp4b1 Mouse ozone multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CYP4B1 mRNA more ... CTD PMID:32699268 Cyp4b1 Mouse paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CYP4B1 mRNA CTD PMID:17562736 Cyp4b1 Mouse paracetamol decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYP4B1 mRNA CTD PMID:29067470 Cyp4b1 Mouse pentane-2,3-dione decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 2 and 3-pentanedione results in decreased expression of CYP4B1 mRNA CTD PMID:25710175 Cyp4b1 Mouse perfluorooctane-1-sulfonic acid increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 perfluorooctane sulfonic acid results in increased expression of CYP4B1 mRNA CTD PMID:18692542 Cyp4b1 Mouse perfluorooctanoic acid increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of CYP4B1 mRNA CTD PMID:16221955 and PMID:28511854 Cyp4b1 Mouse perfluorooctanoic acid multiple interactions ISO Cyp4b1 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CYP4B1 mRNA CTD PMID:35163327 Cyp4b1 Mouse phenobarbital increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of CYP4B1 mRNA CTD PMID:12082028 and PMID:23273579 Cyp4b1 Mouse phenobarbital decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Phenobarbital results in decreased expression of CYP4B1 mRNA CTD PMID:30047161 Cyp4b1 Mouse phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CYP4B1 mRNA CTD PMID:23091169 Cyp4b1 Mouse pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CYP4B1 mRNA CTD PMID:18467677 Cyp4b1 Mouse pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYP4B1 mRNA CTD PMID:17426115 and PMID:23811191 Cyp4b1 Mouse pirinixic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CYP4B1 mRNA] CTD PMID:18467677 Cyp4b1 Mouse potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of CYP4B1 mRNA CTD PMID:23608068 Cyp4b1 Mouse pregnenolone 16alpha-carbonitrile decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP4B1 mRNA CTD PMID:15596064 Cyp4b1 Mouse progesterone multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in increased expression of CYP4B1 mRNA CTD PMID:17404688 Cyp4b1 Mouse progesterone increases expression ISO CYP4B1 (Homo sapiens) 6480464 Progesterone results in increased expression of CYP4B1 mRNA CTD PMID:17404688 Cyp4b1 Mouse propylparaben decreases expression ISO CYP4B1 (Homo sapiens) 6480464 propylparaben results in decreased expression of CYP4B1 mRNA CTD PMID:38568856 Cyp4b1 Mouse resveratrol multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP4B1 mRNA CTD PMID:23557933 Cyp4b1 Mouse ritonavir affects expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Ritonavir affects the expression of CYP4B1 mRNA CTD PMID:17719200 Cyp4b1 Mouse ritonavir decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Ritonavir results in decreased expression of CYP4B1 mRNA CTD PMID:17719200 Cyp4b1 Mouse rotenone increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Rotenone results in increased expression of CYP4B1 mRNA CTD PMID:28374803 Cyp4b1 Mouse selenium atom increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Selenium deficiency results in increased expression of CYP4B1 mRNA CTD PMID:11444866 Cyp4b1 Mouse silicon dioxide decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of CYP4B1 mRNA CTD PMID:22300531 Cyp4b1 Mouse skatole multiple interactions ISO CYP4B1 (Homo sapiens) 6480464 [CYP4B1 protein results in increased metabolism of Skatole] which results in increased chemical synthesis of 3-methyleneindolenine CTD PMID:20187624 Cyp4b1 Mouse skatole increases metabolic processing ISO CYP4B1 (Homo sapiens) 6480464 CYP4B1 protein results in increased metabolism of Skatole CTD PMID:20187624 Cyp4b1 Mouse sodium arsenite affects methylation ISO CYP4B1 (Homo sapiens) 6480464 sodium arsenite affects the methylation of CYP4B1 gene CTD PMID:28589171 Cyp4b1 Mouse sodium arsenite decreases expression ISO CYP4B1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CYP4B1 mRNA CTD PMID:29301061 and PMID:38568856 Cyp4b1 Mouse succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4B1 mRNA CTD PMID:26378955 Cyp4b1 Mouse sulfadimethoxine decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Sulfadimethoxine results in decreased expression of CYP4B1 mRNA CTD PMID:30047161 Cyp4b1 Mouse sulindac multiple interactions ISO Cyp4b1 (Rattus norvegicus) 6480464 [Sulindac co-treated with lipopolysaccharide and E coli O55-B5] affects the expression of CYP4B1 mRNA CTD PMID:20371263 Cyp4b1 Mouse tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of CYP4B1 mRNA CTD PMID:17555576 Cyp4b1 Mouse terephthalic acid increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 terephthalic acid results in increased expression of CYP4B1 mRNA CTD PMID:16673812 Cyp4b1 Mouse Tesaglitazar increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 tesaglitazar results in increased expression of CYP4B1 mRNA CTD PMID:21515302 Cyp4b1 Mouse testosterone increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Testosterone results in increased expression of CYP4B1 mRNA CTD PMID:11311483 Cyp4b1 Mouse testosterone multiple interactions ISO Cyp4b1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of CYP4B1 mRNA CTD PMID:26496021 Cyp4b1 Mouse tetrachloromethane affects expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Carbon Tetrachloride affects the expression of CYP4B1 mRNA CTD PMID:16239168 Cyp4b1 Mouse Theaflavin 3,3'-digallate affects expression ISO CYP4B1 (Homo sapiens) 6480464 theaflavin-3 and 3'-digallate affects the expression of CYP4B1 mRNA CTD PMID:34925699 Cyp4b1 Mouse thiram decreases expression ISO CYP4B1 (Homo sapiens) 6480464 Thiram results in decreased expression of CYP4B1 mRNA CTD PMID:38568856 Cyp4b1 Mouse titanium dioxide decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 titanium dioxide results in decreased expression of CYP4B1 mRNA CTD PMID:30012374 Cyp4b1 Mouse titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CYP4B1 mRNA CTD PMID:35295148 Cyp4b1 Mouse titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4B1 mRNA CTD PMID:29950665 Cyp4b1 Mouse toluene affects expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Toluene affects the expression of CYP4B1 mRNA CTD PMID:18653662 Cyp4b1 Mouse trichloroethene decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of CYP4B1 mRNA CTD PMID:33387578 Cyp4b1 Mouse triclosan increases expression ISO CYP4B1 (Homo sapiens) 6480464 Triclosan results in increased expression of CYP4B1 mRNA CTD PMID:29849464 Cyp4b1 Mouse trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of CYP4B1 mRNA CTD PMID:19042947 Cyp4b1 Mouse troglitazone increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 troglitazone results in increased expression of CYP4B1 mRNA CTD PMID:21515302 Cyp4b1 Mouse valproic acid decreases methylation ISO CYP4B1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of CYP4B1 gene CTD PMID:29501571 Cyp4b1 Mouse valproic acid decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Valproic Acid results in decreased expression of CYP4B1 mRNA CTD PMID:35594946 Cyp4b1 Mouse vinclozolin affects expression ISO Cyp4b1 (Rattus norvegicus) 6480464 vinclozolin affects the expression of CYP4B1 mRNA CTD PMID:19015723 Cyp4b1 Mouse zinc atom decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Zinc deficiency results in decreased expression of CYP4B1 mRNA CTD PMID:12672911 Cyp4b1 Mouse zinc atom increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Zinc deficiency results in increased expression of CYP4B1 mRNA and Zinc results in increased expression of CYP4B1 mRNA CTD PMID:11717422 and PMID:17074742 Cyp4b1 Mouse zinc sulfate increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Zinc Sulfate results in increased expression of CYP4B1 mRNA CTD PMID:17074742 Cyp4b1 Mouse zinc(0) decreases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Zinc deficiency results in decreased expression of CYP4B1 mRNA CTD PMID:12672911 Cyp4b1 Mouse zinc(0) increases expression ISO Cyp4b1 (Rattus norvegicus) 6480464 Zinc deficiency results in increased expression of CYP4B1 mRNA and Zinc results in increased expression of CYP4B1 mRNA CTD PMID:11717422 and PMID:17074742 Cyp4b1 Mouse zoledronic acid increases expression ISO CYP4B1 (Homo sapiens) 6480464 zoledronic acid results in increased expression of CYP4B1 mRNA CTD PMID:24714768
1,2-dimethylhydrazine (EXP) 1-naphthyl isothiocyanate (ISO) 17alpha-ethynylestradiol (EXP,ISO) 17beta-estradiol (EXP,ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (ISO) 2-naphthylamine (EXP,ISO) 3,3',4,4',5-pentachlorobiphenyl (ISO) 3,3'-Dichlorobenzidine (EXP,ISO) 3,4-methylenedioxymethamphetamine (EXP) 3-chloropropane-1,2-diol (EXP) 3-isobutyl-1-methyl-7H-xanthine (ISO) 3-methylbenzyl alcohol (ISO) 3-methylcholanthrene (ISO) 3-methyleneindolenine (ISO) 3H-1,2-dithiole-3-thione (ISO) 4,4'-sulfonyldiphenol (EXP) 4-Ipomeanol (EXP,ISO) 6-propyl-2-thiouracil (ISO) acrolein (ISO) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) alpha-pinene (ISO) alpha-Zearalanol (ISO) amitrole (ISO) ammonium chloride (ISO) amphotericin B (ISO) aristolochic acid A (ISO) Azoxymethane (EXP) benzo[a]pyrene (EXP,ISO) benzo[b]fluoranthene (EXP) Benzo[ghi]perylene (ISO) beta-naphthoflavone (ISO) bezafibrate (ISO) bifenthrin (EXP) bisphenol A (EXP,ISO) buspirone (ISO) cadmium dichloride (EXP,ISO) caffeine (ISO) calcidiol (ISO) calcitriol (ISO) carbon nanotube (EXP) chlorpyrifos (EXP) ciguatoxin CTX1B (EXP) cobalt atom (EXP) cobalt dichloride (ISO) copper atom (ISO) copper(0) (ISO) copper(II) chloride (ISO) Cuprizon (ISO) cyclosporin A (ISO) dexamethasone (ISO) dextran sulfate (EXP) dodecanoic acid (EXP) elemental selenium (ISO) epoxiconazole (ISO) ethanol (ISO) ethyl methanesulfonate (ISO) fenofibrate (ISO) fenthion (EXP) flavonoids (ISO) flutamide (ISO) folic acid (EXP) genistein (EXP,ISO) glycidol (EXP) indometacin (ISO) irinotecan (ISO) ketoconazole (ISO) kojic acid (EXP,ISO) lead diacetate (ISO) levofloxacin (ISO) m-tolualdehyde (ISO) m-xylene (ISO) methimazole (ISO) methylparaben (ISO) mifepristone (ISO) Muraglitazar (ISO) N-nitrosodiethylamine (EXP,ISO) nevirapine (ISO) O-methyleugenol (ISO) okadaic acid (ISO) orphenadrine (ISO) oxycodone (ISO) ozone (EXP,ISO) paracetamol (EXP,ISO) pentane-2,3-dione (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (ISO) phenobarbital (EXP,ISO) pirinixic acid (EXP) potassium dichromate (EXP) pregnenolone 16alpha-carbonitrile (ISO) progesterone (ISO) propylparaben (ISO) resveratrol (ISO) ritonavir (ISO) rotenone (ISO) selenium atom (ISO) silicon dioxide (ISO) skatole (ISO) sodium arsenite (ISO) succimer (EXP) sulfadimethoxine (ISO) sulindac (ISO) tamoxifen (EXP) terephthalic acid (ISO) Tesaglitazar (ISO) testosterone (ISO) tetrachloromethane (ISO) Theaflavin 3,3'-digallate (ISO) thiram (ISO) titanium dioxide (EXP,ISO) toluene (ISO) trichloroethene (ISO) triclosan (ISO) trimellitic anhydride (EXP) troglitazone (ISO) valproic acid (ISO) vinclozolin (ISO) zinc atom (ISO) zinc sulfate (ISO) zinc(0) (ISO) zoledronic acid (ISO)
Cyp4b1 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 115,481,895 - 115,504,918 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 115,481,922 - 115,504,920 (-) Ensembl GRCm39 Ensembl GRCm38 4 115,624,698 - 115,647,721 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 115,624,725 - 115,647,723 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 115,297,333 - 115,320,310 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 115,122,660 - 115,145,637 (-) NCBI MGSCv36 mm8 Celera 4 114,360,727 - 114,383,719 (-) NCBI Celera Cytogenetic Map 4 D1 NCBI cM Map 4 53.06 NCBI
CYP4B1 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 46,799,046 - 46,819,413 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 46,757,838 - 46,819,413 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 47,264,718 - 47,285,085 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 47,037,257 - 47,057,608 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 46,976,761 - 46,997,105 NCBI Celera 1 45,552,027 - 45,572,396 (+) NCBI Celera Cytogenetic Map 1 p33 NCBI HuRef 1 45,380,284 - 45,400,633 (+) NCBI HuRef CHM1_1 1 47,381,383 - 47,401,714 (+) NCBI CHM1_1 T2T-CHM13v2.0 1 46,676,425 - 46,696,812 (+) NCBI T2T-CHM13v2.0
Cyp4b1 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 134,375,807 - 134,413,635 (-) NCBI GRCr8 mRatBN7.2 5 129,139,019 - 129,176,860 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 129,139,038 - 129,156,348 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 131,749,529 - 131,766,903 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 133,504,409 - 133,521,783 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 133,526,563 - 133,543,937 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 134,508,728 - 134,526,103 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 134,508,730 - 134,526,089 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 138,299,551 - 138,316,860 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 135,917,327 - 135,934,636 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 135,922,552 - 135,939,862 (-) NCBI Celera 5 127,676,727 - 127,694,036 (-) NCBI Celera RH 3.4 Map 5 823.3 RGD Cytogenetic Map 5 q35 NCBI
LOC102012414 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955464 11,378,980 - 11,556,544 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955464 11,539,467 - 11,556,519 (-) NCBI ChiLan1.0 ChiLan1.0
CYP4B1 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 179,984,908 - 180,003,684 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 179,126,616 - 179,145,387 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 46,107,787 - 46,127,162 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 47,462,178 - 47,481,502 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 47,462,178 - 47,481,502 (+) Ensembl panpan1.1 panPan2
CYP4B1 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 15 13,676,631 - 13,694,483 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 15 13,676,371 - 13,694,705 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 15 13,796,940 - 13,814,798 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 15 13,826,980 - 13,844,834 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 15 13,826,737 - 13,844,877 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 15 13,628,060 - 13,645,902 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 15 13,696,377 - 13,714,240 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 15 13,765,891 - 13,783,754 (-) NCBI UU_Cfam_GSD_1.0
LOC101955242 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405058 61,881,092 - 61,957,546 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936474 27,767,371 - 27,782,008 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936474 27,705,874 - 27,782,328 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
CYP4B1 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 6 164,718,444 - 164,737,552 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 6 164,718,393 - 164,737,693 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 6 152,210,031 - 152,229,243 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
CYP4B1 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 20 85,997,796 - 86,018,649 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 20 85,996,269 - 86,018,055 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666033 30,987,875 - 31,007,108 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
LOC101725929
.
Predicted Target Of
Count of predictions: 313 Count of miRNA genes: 263 Interacting mature miRNAs: 288 Transcripts: ENSMUST00000102707, ENSMUST00000135569, ENSMUST00000143237, ENSMUST00000145841 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
13824982 Svwq1_m seminal vesicle weight QTL 1 (mouse) 4 89888237 118857197 Mouse 11532714 Sluc43_m susceptibility to lung cancer 43 (mouse) 4 46642108 123127211 Mouse 10047132 Albq19_m albuminuria QTL 19 (mouse) Not determined 4 112824389 146824389 Mouse 12904002 Opfaq9_m open field activity QTL 9 (mouse) 4 92975790 126975790 Mouse 4141623 W6q13_m weight 6 weeks QTL 13 (mouse) Not determined 88982069 140468203 Mouse 12910797 Pwgrq4_m pre-weaning growth rate QTL 4 (mouse) 4 105835310 141433838 Mouse 25314312 Syncl2_m synaptonemal complex length 2 (mouse) 4 65718237 146584457 Mouse 1357726 Lnopy1_m lens opacity 1 (mouse) Not determined 4 85428838 119429037 Mouse 12910794 Pwbwq8_m post-weaning body weight QTL 8 (mouse) 4 105835310 141433838 Mouse 14696689 Gdq2_m grooming duration QTL 2, females (mouse) 4 100857197 124893793 Mouse 1300743 Skull6_m skull morphology 6 (mouse) Not determined 4 111009051 145009280 Mouse 1301382 Arvm2_m autoimmune renal vasculitis 2 (mouse) Not determined 4 107791564 141791756 Mouse 12910813 Pwbwq4_m pre-weaning body weight QTL 4 (mouse) 4 105835310 141433838 Mouse 4141093 W3q17_m weight 3 weeks QTL 17 (mouse) Not determined 88982069 140468203 Mouse 12910808 Pwbwq9_m post-weaning body weight QTL 9 (mouse) 4 105835310 141433838 Mouse 27095939 Ulnl9_m ulna length 9, 16 week (mouse) 4 65318237 118857197 Mouse 11567249 Elorr3_m ethanol induced loss of righting response 3 (mouse) 4 3722677 156268235 Mouse 1301815 Sles2_m systemic lupus erythmatosus suppressor 2 (mouse) Not determined 4 94957579 150676858 Mouse 1300663 Start2_m startle response 2 (mouse) Not determined 4 107264957 141265153 Mouse 1300918 Stheal4_m soft tissue heal 4 (mouse) Not determined 4 89969627 123969747 Mouse 1301556 Cd4vts1_m CD4 virgin T cell subset 1 (mouse) Not determined 4 85428838 119429037 Mouse 1301823 Bmd7_m bone mineral density 7 (mouse) Not determined 4 88982069 151654550 Mouse 1302204 Spm1_m splenomegaly modifier (mouse) Not determined 4 82244395 116244582 Mouse 10412072 Ssen1_m suseptibility to Sendai virus 1 (mouse) Not determined 4 109658132 133154782 Mouse 1301930 Papg1_m pulmonary adenoma progression 1 (mouse) Not determined 4 85781167 119781279 Mouse 13208562 Wght7_m weight 7 (mouse) 4 90888237 148084457 Mouse 13208565 Bmiq6_m body mass index QTL 6 (mouse) 4 110857197 125893793 Mouse 1300655 Nidds_m non-insulin-dependent diabetes mellitus in SJL (mouse) Not determined 4 115030777 129465915 Mouse 1300781 Lith8_m lithogenic gene 8 (mouse) Not determined 4 107264957 141265153 Mouse 39128212 Lwq21_m liver weight QTL 21 (mouse) 4 88982069 140468203 Mouse 1300689 Dob1_m Dietary obesity 1 (mouse) Body weight 4 101574601 123127211 Mouse 27226716 Metcl2_m metatarsal-calcaneal length 2, 5 week (mouse) 4 88118237 118557197 Mouse 1301847 Fecq2_m fecundity QTL 2 (mouse) Not determined 4 100071971 134072206 Mouse 26884445 Sklq7_m skull length QTL 7, 10 week (mouse) 4 68018237 150884457 Mouse 1301597 Anxty_m anxiety (mouse) Not determined 4 74137574 128009280 Mouse 26884437 Sklq13_m skull length QTL 13, 16 week (mouse) 4 57700000 155684457 Mouse 4141549 W10q10_m weight 10 weeks QTL 10 (mouse) Not determined 88982069 140468203 Mouse 1357895 Ctrcts_m cataract severity (mouse) Not determined 4 45709925 138342753 Mouse 1300809 Ccrs2_m corpus callosum hemisphere surface size 2 (mouse) Not determined 4 107264957 141265153 Mouse 4142047 Mvwf3_m modifier of von Willebrand factor 3 (mouse) Not determined 14010457 117072206 Mouse 1301106 Skts7_m skin tumor susceptibility 7 (mouse) Not determined 4 100071971 134072206 Mouse 1301233 Sbw2_m splenomegaly-NZB x NZW 2 (mouse) Not determined 4 94957579 128009280 Mouse 10755520 Rbc1_m red blood cell count 1 (mouse) 4 108477692 142477692 Mouse 10755521 Hct1_m hematocrit 1 (mouse) 4 108477692 142477692 Mouse 10755522 Hgb1_m hemoglobin 1 (mouse) 4 108477692 142477692 Mouse 27095924 Pglq2_m pelvic girdle length QTL 2, 5 week (mouse) 4 69118237 130727311 Mouse 1301118 Bbaa23_m B.burgdorferi-associated arthritis 23 (mouse) Not determined 4 85781167 119781279 Mouse 11532738 Abd1_m autoimmune biliary disease 1 (mouse) 4 88982069 116271120 Mouse 15039368 Nmrs19_m NAFLD-associated magnetic resonance shift 19 (mouse) 4 90882780 124882780 Mouse 27095917 Scvln14_m sacral vertebrae length 2, 16 week (mouse) 4 68018237 130277062 Mouse 1301731 Cafq2_m caffeine metabolism QTL 2 (mouse) Not determined 4 94732255 128732454 Mouse 4141900 Skts-fp1_m skin tumor susceptibility in FVB and PWK 1 (mouse) Not determined 4 53550839 124055180 Mouse 15039382 Ltgq7_m liver triglyceride QTL 7 (mouse) 4 105705794 139705794 Mouse 15039377 Bw45_m body weight QTL 45 (mouse) 4 105705794 139705794 Mouse 1300839 Dyscalc2_m dystrophic cardiac calcinosis 2 (mouse) Not determined 4 111009051 145009280 Mouse 12880433 Fgf23lq1_m FGF23 serum level QTL 1 (mouse) 4 101157197 135157197 Mouse 4141001 Tgq17_m triglyceride QTL 17 (mouse) Not determined 112523489 146523489 Mouse 1300580 Lbw2_m lupus NZB x NZW 2 (mouse) Not determined 4 98545539 128009280 Mouse 15039378 Adip30_m adiposity 30 (mouse) 4 105705794 139705794 Mouse 1301867 Idd11_m insulin dependent diabetes susceptibility 11 (mouse) Not determined 4 83604870 117605006 Mouse 26884449 Sklq2_m skull length QTL 2, 5 week (mouse) 4 36700000 128993793 Mouse 27095905 Scvln3_m sacral vertebrae length 2, 5 week (mouse) 4 55600000 128993793 Mouse 1357800 Tgq3_m triglyceride QTL 3 (mouse) Not determined 4 107055093 141055180 Mouse 15039385 Mvlq3_m macrovesicular liver lesion QTL 3 (mouse) 4 112182386 146182386 Mouse 11553870 Cmmm_m carcinoma modifier of MSM (mouse) 4 90590668 124590781 Mouse
D50834
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 4 115,582,057 - 115,582,238 UniSTS GRCm38 GRCm38 4 115,624,800 - 115,624,997 UniSTS GRCm38 MGSCv37 4 115,254,662 - 115,254,843 UniSTS GRCm37 MGSCv37 4 115,297,405 - 115,297,602 UniSTS GRCm37 Celera 4 114,321,312 - 114,321,493 UniSTS Celera 4 114,360,799 - 114,360,996 UniSTS Cytogenetic Map 4 D1 UniSTS cM Map 4 49.5 UniSTS Whitehead/MRC_RH 4 1544.23 UniSTS Whitehead_YAC 4 UniSTS
Cyp4b1
Mouse Assembly Chr Position (strand) Source JBrowse Cytogenetic Map 4 D1 UniSTS cM Map 4 49.5 UniSTS
D50834
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 4 115,624,796 - 115,624,929 UniSTS GRCm38 GRCm38 4 115,582,053 - 115,582,170 UniSTS GRCm38 MGSCv37 4 115,297,401 - 115,297,534 UniSTS GRCm37 MGSCv37 4 115,254,658 - 115,254,775 UniSTS GRCm37 Celera 4 114,321,308 - 114,321,425 UniSTS Celera 4 114,360,795 - 114,360,928 UniSTS Cytogenetic Map 4 D1 UniSTS Whitehead/MRC_RH 4 1544.23 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
Ensembl Acc Id:
ENSMUST00000102707 ⟹ ENSMUSP00000099768
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 115,481,922 - 115,504,920 (-) Ensembl GRCm38.p6 Ensembl 4 115,624,725 - 115,647,723 (-) Ensembl
Ensembl Acc Id:
ENSMUST00000135569 ⟹ ENSMUSP00000142279
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 115,481,922 - 115,497,625 (-) Ensembl GRCm38.p6 Ensembl 4 115,624,725 - 115,640,428 (-) Ensembl
Ensembl Acc Id:
ENSMUST00000143237
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 115,485,659 - 115,493,109 (-) Ensembl GRCm38.p6 Ensembl 4 115,628,462 - 115,635,912 (-) Ensembl
Ensembl Acc Id:
ENSMUST00000145841 ⟹ ENSMUSP00000118323
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 115,482,843 - 115,499,096 (-) Ensembl GRCm38.p6 Ensembl 4 115,625,646 - 115,641,899 (-) Ensembl
RefSeq Acc Id:
NM_007823 ⟹ NP_031849
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 4 115,481,895 - 115,504,918 (-) NCBI GRCm38 4 115,624,698 - 115,647,721 (-) NCBI MGSCv37 4 115,297,333 - 115,320,310 (-) RGD Celera 4 114,360,727 - 114,383,719 (-) RGD cM Map 4 ENTREZGENE
Sequence:
AGGCAGTTGGAGCCTGGGTCCTGCGAGTTTAGCCATGGCGCTCAGCTTTCTCTCTCCAAGCCTTTCCCGCCTCGGCCTGTGGGCTTCTGTAGTGATCCTGATGGTAACCGTCCTGAAGCTCCTCAGCC
hide sequence
RefSeq Acc Id:
NP_031849 ⟸ NM_007823
- UniProtKB:
Q64462 (UniProtKB/Swiss-Prot), Q3TNA0 (UniProtKB/TrEMBL)
- Sequence:
MALSFLSPSLSRLGLWASVVILMVTVLKLLSLLFRRQKLARALDSFPGPPKHWLFGHALEIQKTGGLDKVVTWTEQFPYAHPLWLGQFIVFLNIYEPDYAKAVYSRGDPKAAYVYDFFLQWIGKGLLV
hide sequence
Ensembl Acc Id:
ENSMUSP00000118323 ⟸ ENSMUST00000145841
Ensembl Acc Id:
ENSMUSP00000142279 ⟸ ENSMUST00000135569
Ensembl Acc Id:
ENSMUSP00000099768 ⟸ ENSMUST00000102707
RGD ID: 6835107 Promoter ID: MM_KWN:39091 Type: Non-CpG SO ACC ID: SO:0000170 Source: MPROMDB Tissues & Cell Lines: Kidney Transcripts: OTTMUST00000019681 Position: Mouse Assembly Chr Position (strand) Source MGSCv36 4 115,308,476 - 115,308,976 (-) MPROMDB
RGD ID: 6835106 Promoter ID: MM_KWN:39094 Type: Non-CpG SO ACC ID: SO:0000170 Source: MPROMDB Tissues & Cell Lines: Kidney, Lung Transcripts: ENSMUST00000030482, ENSMUST00000102707 Position: Mouse Assembly Chr Position (strand) Source MGSCv36 4 115,320,044 - 115,320,544 (-) MPROMDB
RGD ID: 6884258 Promoter ID: EPDNEW_M5579 Type: single initiation site Name: Cyp4b1_1 Description: Mus musculus cytochrome P450, family 4, subfamily b, polypeptide1 , mRNA. SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Mouse Assembly Chr Position (strand) Source GRCm38 4 115,647,721 - 115,647,781 EPDNEW
